From our survey
MO HealthNet, work plans, Medicare, TRICARE and no insurance: where each starts, whether cash is worth it, and why your doctor matters.
When depression has not budged after one medication, then another, the questions that come next are often about money. Will my plan pay? What if it says no? Is there a cheaper way? This FAQ collects the questions Missourians most often raise about insurance and newer treatments for stubborn depression, with plain answers.
One number from our summer poll frames everything else. Of the 443 Midwest adults we surveyed across ten states, 65 percent ranked coverage as the deciding or a big factor for trying ketamine or esketamine. Pollfish has validated them, and they are final.
Yes. Beyond that 65 percent, another 21 percent in our survey said coverage would count as some factor, which means only 14 percent would set it aside entirely. Caring about cost is not a sign that you care less about getting well.
Esketamine, sold as Spravato, comes as a nasal spray and is approved for grown patients whose depression outlasted other medicines. You take it only at a certified clinic, under staff supervision, then stay two hours or longer, and you arrange a ride because driving waits until tomorrow.
Ketamine is a related drug. Some clinics offer it through IV infusions, and some programs offer at-home forms. Those uses are outside the specific approval that esketamine has for depression, and they are often paid for differently. When you talk to your plan or a clinic, name which one you mean.
Broadly, it means depression that earlier antidepressants did not improve enough. Insurers that cover esketamine commonly ask for records showing that history. Your prescriber usually handles that documentation, but it helps if you can recall which medications you took and roughly for how long.
MO HealthNet is Missouri's Medicaid program. Most members are assigned to a managed care company, listed with its phone number on the card. Call that number and ask:
That last question is worth asking because esketamine visits require a ride home. You are also not alone in this. In our survey, Medicaid was the second most common type of coverage respondents reported, at 37 percent, just behind commercial plans.
Not necessarily. Commercial plans came in at 39 percent in our survey, the most common type and nearly tied with Medicaid, and they vary widely from employer to employer. Esketamine may sit on the pharmacy side of one plan and the medical side of another. Some use a separate behavioral health company. Ask your plan which benefit applies and whether the site you are considering is in network for that benefit.
Medicare was reported by 23 percent of our respondents and TRICARE by 5 percent. Both can be more complicated than a single yes or no, because coverage may depend on how the medication and the supervised visit are billed. Call Medicare or your Medicare Advantage plan, or TRICARE, and ask the same core questions: covered, prior authorization, and in-network sites near you.
Nine percent of the people we surveyed reported having no coverage. If that is you, ask any clinic you contact about self-pay pricing in writing, and whether they know of manufacturer assistance or community programs. Also ask your primary doctor or a community health center about lower-cost options for depression care in general, since esketamine is only one path.
That is a personal call. Our poll put it plainly, insured with extra steps or cash-pay and simpler, and 51 percent took insurance, 23 percent cash, and 26 percent could not decide. There is no single right answer, but it helps to get both prices before you decide.
No. It helps to make one call to your plan first, but your doctor is part of the process. Our respondents would start with a primary doctor (56 percent) or a psychiatrist (23 percent). Tell your doctor early that coverage matters to you. That shapes where they refer you.
Because it is the thing most people actually act on. In our poll, 74 percent pointed to their doctor's recommendation as the push they would need. Very few pointed to an ad. And because your doctor documents your history, their support is often central to a prior authorization.
That depends on where you live and which sites your plan covers. In rural parts of Missouri, the nearest certified site could be a significant drive, and each visit needs a driver. After insurance, the provider trait our respondents picked most often was a location near home, at 43 percent. Brain Recovery Centers explains esketamine costs and coverage for Missourians mapping their options. Ask your plan for the nearest in-network sites and map them before you commit.
No. Nobody can promise an outcome from any depression treatment, and esketamine has one approved use that does not fit everyone. You and your clinician decide; none of this FAQ is medical advice.
Then set the insurance questions aside for today. From anywhere in Missouri, pick up the phone. A call or a text to 988 brings the Suicide and Crisis Lifeline, without charge, in confidence, every hour. No plan, card, or perfect wording is needed.
Pollfish ran survey 395586438 through its panel of consumers until the June 23, 2026 close, gathering 443 finished questionnaires from people aged 18 through 64 in Kansas, Iowa, Minnesota, Missouri, Oklahoma, Nebraska, Ohio, Wisconsin, Illinois and Indiana. Coverage type was multi-select, so it sums past 100. Validation has closed, so the percentages are final. Underwriting and the commission came from the publisher.